Levon M. Khachigian

15.9k total citations
207 papers, 9.9k citations indexed

About

Levon M. Khachigian is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Levon M. Khachigian has authored 207 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Molecular Biology, 44 papers in Cancer Research and 30 papers in Immunology. Recurrent topics in Levon M. Khachigian's work include Angiogenesis and VEGF in Cancer (30 papers), Advanced biosensing and bioanalysis techniques (24 papers) and RNA Interference and Gene Delivery (23 papers). Levon M. Khachigian is often cited by papers focused on Angiogenesis and VEGF in Cancer (30 papers), Advanced biosensing and bioanalysis techniques (24 papers) and RNA Interference and Gene Delivery (23 papers). Levon M. Khachigian collaborates with scholars based in Australia, United States and United Kingdom. Levon M. Khachigian's co-authors include Tucker Collins, Mary M. Kavurma, Harry C. Lowe, Amy J. Williams, Tucker Collins, Fernando S. Santiago, Colin N. Chesterman, Crispin R. Dass, Roger G. Fahmy and Volkhard Lindner and has published in prestigious journals such as Science, The Lancet and Nucleic Acids Research.

In The Last Decade

Levon M. Khachigian

204 papers receiving 9.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levon M. Khachigian Australia 54 6.2k 1.7k 1.5k 1.1k 1.1k 207 9.9k
Grietje Molema Netherlands 56 4.9k 0.8× 1.2k 0.7× 1.6k 1.1× 1.3k 1.2× 1.0k 1.0× 229 10.3k
Anton Jan van Zonneveld Netherlands 57 5.0k 0.8× 3.1k 1.9× 1.1k 0.8× 874 0.8× 1.3k 1.2× 211 10.6k
Raija Sormunen Finland 50 5.3k 0.9× 1.7k 1.0× 965 0.6× 891 0.8× 879 0.8× 177 9.0k
Carmelo Bernabéu Spain 60 5.9k 1.0× 1.6k 0.9× 1.9k 1.2× 1.7k 1.5× 1.2k 1.2× 216 11.7k
Min Wang China 66 7.8k 1.3× 2.3k 1.4× 2.0k 1.3× 2.4k 2.2× 789 0.7× 417 14.0k
Xiao Yang China 67 10.1k 1.6× 3.0k 1.8× 1.5k 1.0× 2.2k 2.0× 1.1k 1.1× 314 15.0k
Moin A. Saleem United Kingdom 67 5.8k 0.9× 737 0.4× 1.7k 1.1× 758 0.7× 1.6k 1.5× 324 14.4k
Tatiana V. Byzova United States 50 4.2k 0.7× 1.2k 0.7× 1.4k 0.9× 1.2k 1.1× 1.0k 1.0× 124 8.9k
Paul J. Higgins United States 45 4.0k 0.7× 1.5k 0.9× 1.1k 0.7× 1.2k 1.1× 835 0.8× 226 8.5k
Neil R. Hackett United States 56 7.9k 1.3× 1.8k 1.1× 1.4k 0.9× 2.6k 2.4× 1.4k 1.3× 159 13.2k

Countries citing papers authored by Levon M. Khachigian

Since Specialization
Citations

This map shows the geographic impact of Levon M. Khachigian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levon M. Khachigian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levon M. Khachigian more than expected).

Fields of papers citing papers by Levon M. Khachigian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levon M. Khachigian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levon M. Khachigian. The network helps show where Levon M. Khachigian may publish in the future.

Co-authorship network of co-authors of Levon M. Khachigian

This figure shows the co-authorship network connecting the top 25 collaborators of Levon M. Khachigian. A scholar is included among the top collaborators of Levon M. Khachigian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levon M. Khachigian. Levon M. Khachigian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yue, et al.. (2025). Jun, an Oncological Foe or Friend?. International Journal of Molecular Sciences. 26(2). 555–555. 2 indexed citations
2.
Khoo, Alan Soo Beng, et al.. (2024). Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives. International Journal of Molecular Sciences. 25(5). 2798–2798. 4 indexed citations
3.
Nguyễn, Thành Vinh, et al.. (2023). Personalised Medicine and the Potential Role of Electrospinning for Targeted Immunotherapeutics in Head and Neck Cancer. Nanomaterials. 14(1). 6–6. 3 indexed citations
4.
Noor, Rashed, et al.. (2023). Early Growth Response-1: Friend or Foe in the Heart?. Heart Lung and Circulation. 32(5). e23–e35. 4 indexed citations
5.
Khachigian, Levon M., et al.. (2023). Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors. Arteriosclerosis Thrombosis and Vascular Biology. 43(6). 836–851. 16 indexed citations
6.
Khachigian, Levon M., Gerald Liew, Kelvin Yi Chong Teo, Tien Yin Wong, & Paul Mitchell. (2023). Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration. Journal of Translational Medicine. 21(1). 43 indexed citations
7.
Li, Yue, Ben J. Wu, Md Jakir Hossain, et al.. (2023). Flubendazole inhibits PD-1 and suppresses melanoma growth in immunocompetent mice. Journal of Translational Medicine. 21(1). 467–467. 5 indexed citations
9.
Cho, Eunae Sandra, Fergal J. Moloney, Hong Cai, et al.. (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). The Lancet. 381(9880). 1835–1843. 84 indexed citations
10.
Cho, Eunae Sandra, Hong Cai, Hendrik‐Tobias Arkenau, et al.. (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations
11.
Li, Dongping, Yaroslav Ilnytskyy, Anna Kovalchuk, et al.. (2013). Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer. Oncotarget. 4(9). 1373–1387. 53 indexed citations
12.
Hitchins, Megan P., Robert W. Rapkins, Chau‐To Kwok, et al.. (2011). Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR. Cancer Cell. 20(2). 200–213. 116 indexed citations
14.
Wang, Bo, Levon M. Khachigian, Luke Esau, et al.. (2009). A Key Role for Early Growth Response-1 and Nuclear Factor-κB in Mediating and Maintaining GRO/CXCR2 Proliferative Signaling in Esophageal Cancer. Molecular Cancer Research. 7(5). 755–764. 44 indexed citations
15.
Dass, Crispin R., Levon M. Khachigian, & Peter Choong. (2008). c-Jun knockdown sensitizes osteosarcoma to doxorubicin. Molecular Cancer Therapeutics. 7(7). 1909–1912. 32 indexed citations
16.
Dass, Crispin R., Anna Friedhuber, Levon M. Khachigian, Dave E. Dunstan, & Peter Choong. (2008). Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. Journal of Microencapsulation. 25(6). 421–425. 28 indexed citations
17.
Bhindi, Ravinay, Roger G. Fahmy, Harry C. Lowe, et al.. (2007). Brothers in Arms. American Journal Of Pathology. 171(4). 1079–1088. 98 indexed citations
18.
Eisbacher, Michael, Melissa L. Holmes, Anthea Newton, et al.. (2004). Protein-Protein Interaction between Fli-1 and GATA-1 Mediates Synergistic Expression of Megakaryocyte-Specific Genes through Cooperative DNA Binding. Molecular and Cellular Biology. 24(11). 5088–5088. 7 indexed citations
19.
Parish, Christopher R., Fernando S. Santiago, Harry C. Lowe, et al.. (2003). Blockade of Vascular Smooth Muscle Cell Proliferation and Intimal Thickening After Balloon Injury by the Sulfated Oligosaccharide PI-88. Circulation Research. 92(8). e70–7. 53 indexed citations
20.
Rafty, Louise A. & Levon M. Khachigian. (2002). von Hippel‐Lindau tumor suppressor protein represses platelet‐derived growth factor B‐chain gene expression via the Sp1 binding element in the proximal PDGF‐B promoter. Journal of Cellular Biochemistry. 85(3). 490–495. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026